Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cancer Risk for Women with Subsolid Lung Nodules Is Greater Than That for Men

By HospiMedica International staff writers
Posted on 06 Dec 2015
Results from the US National Lung Screening Trial (NLST) show that women have a 50% higher chance of having hazy, lung nodules, which can result in a much higher risk of lung cancer compared to men.

The study demonstrated the value of Computed Tomography (CT) screening exams in reducing lung cancer mortality. More...
The study was presented at the annual meeting of the Radiological Society of North America (RSNA 2015).

The nodules are classified as solid or subsolid based on how they appear in the CT scan, and their consistency is an indicator of lung cancer risk. The researchers used CT scans from the NLST, a large, randomized control study, which included more than 40% women. The researchers characterized all nodules detected by CT that measured between 4 mm and 30 mm, by consistency and used this information to calculate the relative risk of developing lung cancer for each nodule consistency subtype.

A total of 37.8% of people scanned had a positive screen at least once during the trial and women with ground-glass or part-solid nodules had a significantly higher relative risk of lung cancer than men with the same nodule type. The relative risk of lung cancer when solid nodules were detected in the CT scan was comparable for both sexes, and part-solid nodules had the highest predictive value of cancer in both sexes. Ground glass nodules had the lowest predictive value in men, and solid nodules in women.

The results suggest that women with ground glass nodules should undergo closer follow-up than men, however current guidelines for lung cancer screening do not account for differences in gender when managing nodules with different consistencies.

Lead author of the study, Phillip Boiselle, MD, Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA), and Harvard Medical School (HMS; Boston, MA, USA), said, "We know there are differences in cancer risk among different lung nodule consistencies, but we were unaware of any published reports that looked at the differences in lung cancer risk for nodule subtypes between women and men. The main difference we found was that women were 50 percent more likely than men to have ground-glass nodules and, when these nodules were present, women had a substantially higher risk of developing lung cancer. By looking at the rate at which lung cancers grow on serial CT scans, we can develop a better understanding of how often to obtain follow-up CT scans in men and women.”

Related Links:

Beth Israel Deaconess Medical Center
Harvard Medical School




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.